Feedback

Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction

Affiliation
Clinical Department of Medical, Surgical and Health Sciences ,University of Trieste ,Trieste ,Italy
Stocco, Gabriele;
Affiliation
Pediatric Department ,Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Galletti, Anna;
Affiliation
Department of Life Sciences ,University of Trieste ,Trieste ,Italy
Lucafò, Marianna;
Affiliation
Department of Pediatric Oncohematology Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Giurici, Nagua;
Affiliation
Advanced Translational Diagnostic Laboratory ,Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Curci, Debora;
Affiliation
Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Solidoro, Sara;
Affiliation
Department of Pediatric Oncohematology Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Kiren, Valentina;
Affiliation
Genetics Department ,Institute for Maternal and Child Health-IRCCS Burlo Garofolo ,Trieste ,Italy
Bianco, Anna Monica;
Affiliation
Clinical Department of Medical, Surgical and Health Sciences ,University of Trieste ,Trieste ,Italy
Barbi, Egidio;
Affiliation
Clinical Department of Medical, Surgical and Health Sciences ,University of Trieste ,Trieste ,Italy
D’Adamo, Pio

We report a case of post-awakening recurrent episodes of spontaneous re-sedation and apnea with severe desaturation after procedural sedation with dexmedetomidine and propofol in a leukemic adolescent with an ionic channel variant. The mutation is located in the 3′-UTR regulatory region of SCN9A. We speculate that this variant may affect the stability of the mRNA, making the patient more susceptible to the combined effects of propofol and dexmedetomidine. This is the first pediatric report of late onset re-sedation with apnoea after combined sedation with propofol and dexmedetomidine highlighting the risk of adverse events in selected patients with a genetic increased susceptibility. If validated by further studies, pharmacogenetic testing may be implemented to provide personalized therapies in patients needing anesthesia.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Stocco, Galletti, Lucafò, Giurici, Curci, Solidoro, Kiren, Bianco, Barbi and D’Adamo.

Use and reproduction: